India, June 22 -- Shares of Definium Therapeutics (DFTX) jumped over 50% on Monday morning after the company announced positive topline results from its Phase 3 Emerge study of DT120 in major depressive disorder.
The stock is currently trading at $37.06, up $12.58 or 51.39%, on the Nasdaq. It opened at $38.74 after closing the previous session at $24.48. The stock has traded between $6.34 and $39.16 over the past 52 weeks.
For comments and feedback contact: editorial@rttnews.com
Published by HT Digital Content Services with permission from RTT News....